English   español  

Navegación por Autor rp00364

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
O introducir las primeras letras:  
Mostrando resultados 137 a 156 de 226 < Anterior   Siguiente >
DerechosPreviewFecha Public.TítuloAutor(es)Tipo
openAccessbiomedicines-10-01136-v2.pdf.jpgmay-2022Naphthoquinone as a New Chemical Scaffold for Leishmanicidal Inhibitors of Leishmania GSK-3Sebastián-Pérez, Victor; Martínez de Iturrate, Paula; Nácher-Vázquez, Montserrat CSIC ORCID; Nóvoa, Luis; Pérez, Concepción CSIC ORCID; Campillo, Nuria E. CSIC ORCID ; Gil, Carmen CSIC ORCID ; Rivas, Luis CSIC ORCID artículo
openAccessfphar_alegría-arcos_2022.pdf.jpg17-ago-2022Network pharmacology reveals multitarget mechanism of action of drugs to be repurposed for COVID-19Alegría-Arcos, Melissa; Barbosa, Tábata; Sepúlveda, Felipe; Combariza, Germán; Gonzalez, Janneth; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Ramírez, Davidartículo
closedAccessaccesoRestringido.pdf.jpg10-ene-2023Neuronal lack of PDE7a disrupted working memory, spatial learning, and memory but facilitated cued fear memory in miceLiu, Zizhen; Li, Axiang; Ali, Tahir; He, Kaiwu; Gao, Ruyan; He, Liufang; Qiang, Hao; Li, Tao; Li, Ningning; García, Ana; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Lipina, Tatiana V.; Li, Shupengartículo
closedAccessaccesoRestringido.pdf.jpg2015Neuroprotection of CK-1 inhibitors against TDP-43 and LPS toxicityMartínez Gil, Ana CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Salado, Irene G. CSIC; Gil, Carmen CSIC ORCID ; Morales-García, José A. CSIC ORCID; Pérez Castillo, Ana CSIC ORCIDcomunicación de congreso
closedAccessaccesoRestringido.pdf.jpg2012Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke modelRedondo, Miriam CSIC; Zarruk, Juan G.; Ceballos, Placido CSIC; Pérez, Daniel I. CSIC ORCID; Pérez, Concepción CSIC ORCID; Pérez Castillo, Ana CSIC ORCID; Moro, María A.; Brea, José Manuel; Val, Cristina; Cadavid, María Isabel; Loza, María Isabel; Campillo, Nuria E. CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID artículo
openAccessNatural Products and Bioprospecting_Etxebeste-Mitxeltorena_2024.pdf.jpg2024Neuroprotective properties of exosomes and chitosan nanoparticles of Tomafran, a bioengineered tomato enriched in crocinsEtxebeste-Mitxeltorena, Mikel; Niza, Enrique; Martínez Fajardo, Cristian; Gil, Carmen CSIC ORCID ; Gómez-Gómez, Lourdes; Martínez Gil, Ana CSIC ORCID ; Ahrazem, Oussamaartículo
openAccessEJMECH_N. Campillo.pdf.jpg30-jun-2016New applications for known drugs: Human glycogen synthase kinase 3 inhibitors as modulators of Aspergillus fumigatus growthSebastián-Pérez, Víctor; Manoli, Maria-Tsampika CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Mellado, Emilia; Martínez Gil, Ana CSIC ORCID ; Espeso, Eduardo A. CSIC ORCID ; Campillo, Nuria E. CSIC ORCID artículo
openAccessplos pathogens_cuesta-geijo_2022.pdf.jpg26-ene-2022New insights into the role of endosomal proteins for African swine fever virus infectionCuesta-Geijo, Miguel Ángel CSIC ORCID; García-Dorival, Isabel; Puerto, Ana del CSIC; Urquiza, Jesús; Galindo Barreales, Inmaculada; Barrado-Gil, Lucía CSIC ORCID; Lasala, Fátima; Cayuela, Ana; Sorzano, Carlos Óscar S.; Gil, Carmen CSIC ORCID ; Delgado, Rafael; Alonso Martí, Covadongaartículo
closedAccessaccesoRestringido.pdf.jpg2008Non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: Study of structural requirements for thiadiazolidinone derivativesCastro, Ana CSIC ORCID; Encinas, Arantxa; Gil, Carmen CSIC ORCID ; Bräse, Stefan; Porcal, Williams; Pérez, Concepción CSIC ORCID; Moreno, Javier CSIC ORCID; Martínez Gil, Ana CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2000Nonnucleoside human cytomegalovirus inhibitors: Synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivativesMartínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; Pérez, Concepción CSIC ORCID; Castro, Ana CSIC ORCID; Prieto, Columbiana; Otero, Joaquín; Andrei, G; Snoeck, R.; Balzarini, Jan; De Clercq, Erikartículo
openAccessacs.jmedchem_garcía-rubia_2023.pdf.jpg6-abr-2023N′-phenylacetohydrazide derivatives as potent Ebola virus entry inhibitors with an improved pharmacokinetic profileGarcía-Rubia, Alfonso CSIC; Lasala, Fátima; Ginex, Tiziana CSIC ORCID ; Morales-Tenorio, Marcos CSIC; Olal, Catherine; Heung, Michelle; Oquist Phillips, Mayra Paola; Galindo Barreales, Inmaculada; Cuesta-Geijo, Miguel Ángel CSIC ORCID; Casasnovas, José María CSIC ORCID ; Campillo, Nuria E. CSIC ORCID ; Canales, Ángeles CSIC ORCID; Alonso Martí, Covadonga; Martínez Gil, Ana CSIC ORCID ; Muñoz-Fontela, César; Delgado, Rafael; Gil, Carmen CSIC ORCID artículo
openAccessAbstract_YRS_Nozal_2021.pdf.jpg18-jun-2021O2 Improved controlled release and brain penetration of small molecules with therapeutic potential using PLGA nanoparticlesNozal, Vanesa CSIC ORCID; Rojas-Prats, Elisa CSIC ORCID; Pérez, Daniel I. CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID comunicación de congreso
openAccessWO2016198698A3.pdf.jpg15-dic-2016P38 inhibitors for the treatment and prophylaxis of liver cancerSabio, Guadalupe CSIC ORCID; Tomás Loba, Antonia; Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; González Terán, Bárbara; Manieri, Elisasolicitud de patente
openAccessWO2016198698A2.pdf.jpg15-dic-2016P38 inhibitors for the treatment and prophylaxis of liver cancerSabio, Guadalupe CSIC ORCID; Tomás Loba, Antonia; Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID ; González Terán, Bárbara; Manieri, Elisasolicitud de patente
openAccessMestre et al_revised_.BJP_2015.pdf.jpg14-jul-2015PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosisMestre, Leyre CSIC ORCID ; Redondo, Miriam CSIC; Carrillo-Salinas, F. J. CSIC ORCID; Morales-García, José A. CSIC ORCID; Alonso-Gil, Sandra CSIC; Pérez Castillo, Ana CSIC ORCID; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Guaza, Carmen CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2008PDE7 inhibitors as new drugs for neurological and inflammatory disordersGil, Carmen CSIC ORCID ; Campillo, Nuria E. CSIC ORCID ; Pérez, Daniel I. CSIC ORCID; Martínez Gil, Ana CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2017Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson’s diseaseGarcía, Ana M. CSIC ORCID; Salado, Irene G. CSIC; Pérez, Daniel I. CSIC ORCID; Brea, José Manuel; Morales-García, José A. CSIC ORCID; González-García, Alejandro; Cadavid, María Isabel; Loza, María Isabel; Luque, F. Javier; Pérez Castillo, Ana CSIC ORCID; Martínez Gil, Ana CSIC ORCID ; Gil, Carmen CSIC ORCID artículo
closedAccessaccesoRestringido.pdf.jpg2014Phosphodiesterase 10 inhibitors: New disease modifying drugs for Parkinson's disease?García, A. M.; Redondo, M.; Martínez, A.; Gil, Carmen CSIC ORCID artículo
openAccessStem Cells Transl. Med.-Martínez, Ana_2015.pdf.jpg30-jun-2015Phosphodiesterase 7 inhibition induces dopaminergic neurogenesis in hemiparkinsonian ratsMorales-García, José A. CSIC ORCID; Alonso-Gil, Sandra CSIC; Gil, Carmen CSIC ORCID ; Martínez Gil, Ana CSIC ORCID ; Santos, Ángel; Pérez Castillo, Ana CSIC ORCIDartículo
openAccessPhosphodiesterase 7.pdf.jpg24-feb-2011Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson diseaseMorales-García, José A. CSIC ORCID; Redondo, Miriam CSIC; Alonso-Gil, Sandra CSIC; Gil, Carmen CSIC ORCID ; Pérez, Concepción CSIC ORCID; Martínez Gil, Ana CSIC ORCID ; Santos, Ángel; Pérez Castillo, Ana CSIC ORCIDartículo